Pharmaceutical Intermediates Market Overview
Pharmaceutical intermediates are medications that are utilized as raw materials in the manufacture of bulk pharmaceuticals. Furthermore, they are frequently used to describe a material formed during the synthesis of an active pharmaceutical ingredient (API) before it is processed into an API. The global Pharmaceutical Intermediates market is projected to grow at a considerable rate in the coming years.
Every year, the world is experiencing an increase in the number of diseases and patients. Furthermore, the number of physician consultations for infectious and parasitic disorders has soared into the millions, resulting in a surge in demand for a variety of pharmaceuticals. High R&D spending and developments in breakthrough therapeutics are expected to boost the pharmaceutical intermediates market's growth pace in the near future. Furthermore, the growing demand for research and development across the world is escalating the growth of the global pharmaceutical intermediates market in the forecast period. The global pharmaceutical intermediates market is predicted to increase in the near future due to the deployment of standardized pharmaceutical activities and good manufacturing standards (GMP) in pharmaceutical businesses.
On the downside, strict regulatory policies for manufacturers for product quality will hamper the growth of the global Pharmaceutical Intermediates market. However, with an increase in healthcare expenditure, the global pharmaceutical intermediates market is projected to expand at a higher rate in the forthcoming years.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Product, Application, End User, and Region |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | BASF SE, Lonza Group, Evonik Industries AG, Cambrex Corporation, DSM, Aceto, Albemarle Corporation, Vertellus, Chemcon Speciality Chemicals Ltd., chiracon GmbH, A. R. Life Sciences Private Limited. |
Covid-19 Impact on Pharmaceutical Intermediates Market
In addition, the current Pharmaceutical Intermediates Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Pharmaceutical Intermediates Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long-term as well as short-term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Pharmaceutical Intermediates Market Segment Overview
According to End User, the Pharmaceutical & Biotechnology Companies is one of the largest segments in the global Pharmaceutical Intermediates market. The majority of pharmaceutical intermediates are made from high-quality basic materials. In the pharmaceutical and cosmetic sectors, these intermediates are commonly employed. The global pharmaceu5tical intermediates market is developing due to rising demand in these industries. Furthermore, the international chemical industry has seen a significant increase in the manufacturing of pharmaceutical intermediates. The global need for pharmaceutical intermediates is being driven by the increasing chemical industry. Pharmaceutical intermediates are made to order for bulk and specialized manufacturing.
Pharmaceutical Intermediates Market, By Product
- Bulk Drug Intermediate
- Chiral Intermediate
- Achiral Intermediate
- Custom Intermediate
Pharmaceutical Intermediates Market, By Application
· Cardiology
· Oncology
· Endocrinology
· Infectious Diseases
· Orthopedics
· Neurology
· Gastroenterology
· Dermatology
· Inflammatory & Pain Management
· Ophthalmology
· Others
Pharmaceutical Intermediates Market, By End User
· Pharmaceutical & Biotechnology Companies
· CROs & CMOs
Pharmaceutical Intermediates Regional Overview
Region-Wise, North America is expected to hold a maximum share of the pharmaceutical intermediate market. This is mainly because of the growing pharmaceutical manufacturers and consumers in the U.S. and Canada. Furthermore, the rising prevalence of many contagious and chronic diseases has increased demand for pharmaceuticals, which is expected to propel the pharmaceutical intermediates market forward throughout the forecast period. Furthermore, the presence of significant industry players in North America is aiding the growth of the pharmaceutical intermediates market in the region. Moreover, Europe is another major region for the market. Increased demand for enhanced pharmaceutical products is expected to rise market growth during the projected period in this region.
Pharmaceutical Intermediates Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Pharmaceutical Intermediates Market Competitor overview
Some key developments and strategies adopted by manufacturers in Pharmaceutical Intermediates are highlighted below.
· Carlyle commenced its partnership with Viyash in June 2021, when the company acquired a controlling stake in Symed Labs, a leading manufacturer of niche APIs to enable backward integration. Viyash has also acquired a controlling stake in Appco Pharma LLC, US, a formulations player focused on the US market which will help expand access to US generics market and formulation capabilities.
· In November 2021, Global pharmaceutical industry supplier ACG recently announced its plans to invest INR 6 billion (US$80.56 million) to build Asia’s largest capsule manufacturing unit in India. This facility will augment India’s industrial capacity to provide high quality, safe, and affordable medicines and nutraceuticals globally. ACG was founded in Mumbai in 1961 and is now present worldwide, providing integrated solutions for the pharmaceutical and nutraceutical industries.
Pharmaceutical Intermediates Market, Key Players
· BASF SE
· Lonza Group
· Evonik Industries AG
· Cambrex Corporation
· DSM
· Aceto
· Albemarle Corporation
· Vertellus
· Chemcon Speciality Chemicals Ltd.
· chiracon GmbH
· R. Life Sciences Private Limited
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the Pharmaceutical Intermediates market?
High R&D spending and developments in breakthrough therapeutics are expected to boost the pharmaceutical intermediates market's growth pace in the near future
Q2. What are the restraining factors for the Pharmaceutical Intermediates market?
Strict regulatory policies for manufacturers for product quality will hamper the growth of the global Pharmaceutical Intermediates market
Q3. Which segment is projected to hold the largest share in the Pharmaceutical Intermediates Market?
Pharmaceutical & Biotechnology Companies segment is projected to hold the largest share in the Pharmaceutical Intermediates Market
Q4. Which region holds the largest share in the Pharmaceutical Intermediates market?
North America held the largest share in the global Pharmaceutical Intermediates market
Q5. Which are the prominent players in the Pharmaceutical Intermediates Market?
BASF SE, Lonza Group, Evonik Industries AG, Cambrex Corporation, DSM, Aceto, Albemarle Corporation, Vertellus, Chemcon Speciality Chemicals Ltd., chiracon GmbH, A. R. Life Sciences Private Limited. are some key players in the Pharmaceutical Intermediates Market.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Pharmaceutical Intermediates Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Bulk Drug Intermediate
- 5.2.1.1. Chiral Intermediate
- 5.2.1.2. Achiral Intermediate
- 5.2.2. Custom Intermediate
- 5.2.1. Bulk Drug Intermediate
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Cardiology
- 5.3.2. Oncology
- 5.3.3. Endocrinology
- 5.3.4. Infectious Diseases
- 5.3.5. Orthopedics
- 5.3.6. Neurology
- 5.3.7. Gastroenterology
- 5.3.8. Dermatology
- 5.3.9. Inflammatory & Pain Management
- 5.3.10. Ophthalmology
- 5.3.11. Others
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Pharmaceutical & Biotechnology Companies
- 5.4.2. CROs & CMOs
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Pharmaceutical Intermediates Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Bulk Drug Intermediate
- 6.2.1.1. Chiral Intermediate
- 6.2.1.2. Achiral Intermediate
- 6.2.2. Custom Intermediate
- 6.2.1. Bulk Drug Intermediate
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Cardiology
- 6.3.2. Oncology
- 6.3.3. Endocrinology
- 6.3.4. Infectious Diseases
- 6.3.5. Orthopedics
- 6.3.6. Neurology
- 6.3.7. Gastroenterology
- 6.3.8. Dermatology
- 6.3.9. Inflammatory & Pain Management
- 6.3.10. Ophthalmology
- 6.3.11. Others
- 6.4. Market Analysis, Insights and Forecast – By End User
- 6.4.1. Pharmaceutical & Biotechnology Companies
- 6.4.2. CROs & CMOs
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Pharmaceutical Intermediates Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Bulk Drug Intermediate
- 7.2.1.1. Chiral Intermediate
- 7.2.1.2. Achiral Intermediate
- 7.2.2. Custom Intermediate
- 7.2.1. Bulk Drug Intermediate
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Cardiology
- 7.3.2. Oncology
- 7.3.3. Endocrinology
- 7.3.4. Infectious Diseases
- 7.3.5. Orthopedics
- 7.3.6. Neurology
- 7.3.7. Gastroenterology
- 7.3.8. Dermatology
- 7.3.9. Inflammatory & Pain Management
- 7.3.10. Ophthalmology
- 7.3.11. Others
- 7.4. Market Analysis, Insights and Forecast – By End User
- 7.4.1. Pharmaceutical & Biotechnology Companies
- 7.4.2. CROs & CMOs
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Pharmaceutical Intermediates Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Bulk Drug Intermediate
- 8.2.1.1. Chiral Intermediate
- 8.2.1.2. Achiral Intermediate
- 8.2.2. Custom Intermediate
- 8.2.1. Bulk Drug Intermediate
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Cardiology
- 8.3.2. Oncology
- 8.3.3. Endocrinology
- 8.3.4. Infectious Diseases
- 8.3.5. Orthopedics
- 8.3.6. Neurology
- 8.3.7. Gastroenterology
- 8.3.8. Dermatology
- 8.3.9. Inflammatory & Pain Management
- 8.3.10. Ophthalmology
- 8.3.11. Others
- 8.4. Market Analysis, Insights and Forecast – By End User
- 8.4.1. Pharmaceutical & Biotechnology Companies
- 8.4.2. CROs & CMOs
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Pharmaceutical Intermediates Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Bulk Drug Intermediate
- 9.2.1.1. Chiral Intermediate
- 9.2.1.2. Achiral Intermediate
- 9.2.2. Custom Intermediate
- 9.2.1. Bulk Drug Intermediate
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Cardiology
- 9.3.2. Oncology
- 9.3.3. Endocrinology
- 9.3.4. Infectious Diseases
- 9.3.5. Orthopedics
- 9.3.6. Neurology
- 9.3.7. Gastroenterology
- 9.3.8. Dermatology
- 9.3.9. Inflammatory & Pain Management
- 9.3.10. Ophthalmology
- 9.3.11. Others
- 9.4. Market Analysis, Insights and Forecast – By End User
- 9.4.1. Pharmaceutical & Biotechnology Companies
- 9.4.2. CROs & CMOs
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. BASF SE
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Lonza Group
- 10.6. Evonik Industries AG
- 10.7. Cambrex Corporation
- 10.8. DSM
- 10.9. Aceto
- 10.10. Albemarle Corporation
- 10.11. Vertellus
- 10.12. Chemcon Speciality Chemicals Ltd.
- 10.13. chiracon GmbH
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
